Entry details

Schmitt et al. (2002) "A senescence program controlled by p53 and p16INK4a contributes to the outcome of cancer therapy." Cell 109(3):335-346 (PubMed)

Cited by (in linked databases)

  1. TP53, tumor protein p53 GenAge: Human Ageing-Associated Genes
  2. CDKN2A, cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) GenAge: Human Ageing-Associated Genes